OncoDaily
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
OncoDaily
Jul 24, 2023, 18:23 |
Drugs
These drugs are $$$! i.e. avapritinib = $44,000/bottle - Michael Lam
Patients on oral chemo after dose reduction: "I still have these pills at home, but…
Jul 24, 2023, 17:58 |
Drugs
Unfortunately another very expensive drug fail in MDS - Aaron Goodman
Unfortunately another very expensive drug fail in MDS We already have a CURE for MDS…
Jul 24, 2023, 17:49 |
Blog
Happy to be part of the team - Maite Bourlon
Such a wonderful effort!!! Happy to be part of the team Fernando Sabino M…
Jul 24, 2023, 16:28 |
Blog
Are you ready to join the cancerGO movement? - Vino Cherian
No One Should Face Cancer Alone: cancerGO isn't just a project; it's something we care…
Jul 24, 2023, 16:18 |
Blog
So great to spend the day with visionary NCI DIrector Monica Bertagnolli and so many leaders in clinical research - Neal Meropol
So great to spend the day with visionary NCI DIrector Monica Bertagnolli and so many leaders in…
Jul 24, 2023, 15:55 |
Blog
Congratulations to Beth Stewart, MD for being named the 2023 St. Jude "Outstanding Physician" - St. Jude Children's Research Hospital
Congratulations to Beth Stewart, MD, Associate Member in Oncology, for being named the 2023 St.…
Jul 24, 2023, 15:32 |
Positive
The future of Cancer Research is bright - Christine M. Lovly
The future of Cancer Research is bright! Grateful to American Association for Cancer Research, National Cancer Institute (NCI),…
Jul 23, 2023, 17:26 |
Drugs
Myeloma drugs - Dosing and schedule by Vincent Rajkumar on Twitter
Myeloma drugs — Dosing and schedule What I do in practice Dex: 40 mg…
Jul 23, 2023, 17:05 |
Blog
ASCO expert panel chaired by Navneet Singh and Megan Daly has published an update on management of stage III NSCLC based on the ADAURA and KEYNOTE-671 trials - Navneet Singh
Jul 23, 2023, 16:40 |
Blog
The Royal Society of Medicine and London Global Cancer Network are calling for abstract submission for the Vanessa Moss annual prize - Olubukola Ayodele
The Royal Society of Medicine and London Global Cancer Network are calling for abstract submission…
Jul 23, 2023, 16:19 |
Blog
The first oral SERD gets closer to Europe - Paolo Tarantino
Positive CHMP opinion on the marketing authorization of elacestrant for patients with HR+/HER2- MBC with…
Jul 23, 2023, 16:11 |
Societies
We greatly appreciate the Andrew Sabin Family Foundation’s continued support and investment in MD Anderson Cancer Center young talent and their novel ideas
In a post by Peter WT Pisters on Twitter, it says, "We greatly appreciate the…
Jul 23, 2023, 15:57 |
Blog
Craig was able to beat a rare and difficult-to-treat cancer with the help of Amazon benefits - Amazon
Meet Craig. Craig was able to beat a rare and difficult-to-treat cancer with the help…
Jul 23, 2023, 08:01 |
Positive
Increased investment in National Cancer Institute & NIH is an investment in lives - Lisa Lacasse
Thank you to members of Congress represented and staff for joining an important conversation OK…
Jul 23, 2023, 07:51 |
Blog
Will you join me to help save more lives from cancer? - Thomas LeBlanc
I just sent a message to my members of Congress urging them to oppose cuts…
Jul 23, 2023, 07:35 |
Positive
For anyone who's interested in learning research methods in cancer, this is a must-do - Pramesh CS
For anyone who's interested in learning research methods in cancer, this is a must-do. Thanks…
Jul 23, 2023, 07:18 |
Societies
Hope Common Sense Oncology will infuse the spirit of critical appraisal in the hem/onc community, patients, and pt. advocates! - Raj Chakraborty
Excited to see the launch of Common Sense Oncology! Identifying drugs and outcomes that 𝐝𝐨…
Jul 22, 2023, 20:34 |
Positive
I’m running with Fred’s Team and I’m raising money for innovative cancer research at Memorial Sloan - Benoit Rousseau
TRAINING FOR MY FIRST MARATHON TO SUPPORT CANCER RESEARCH! I’m running with Fred’s Team and…
Jul 22, 2023, 19:58 |
Career
I'm incredibly honored to share that I have been selected as a finalist for the Washington Global Health Alliance Rising Star Award - Kingsley I. Ndoh
I'm incredibly honored to share that I have been selected as a finalist for the Washington…
Jul 22, 2023, 19:45 |
Blog
To try and treat and even prevent these late effects of treatment for future generations of childhood cancer survivors - Victoria Forster
The chronic side-effects of childhood cancer treatment are now becoming more well-described, with increasing research…
Jul 22, 2023, 19:34 |
Blog
CRI congratulates SURGE Therapeutics on their completion of a $32 million Series B financing - Cancer Research Institute
CRI congratulates SURGE Therapeutics, led by former CRI CLIP Award Grantee Michael Goldberg, Ph.D, on their completion…
Jul 22, 2023, 19:10 |
Stories
I realized the congruency between an aspect I love of palliative medicine & being a good friend - Toluwalase (Lase) A. Ajayi
I realized the congruency between an aspect I love of palliative medicine & being a…
Jul 22, 2023, 18:50 |
Blog
The five-year survival of all children with acute lymphatic leukemia has continued to increase to 94% - Prinses Máxima Centrum voor kinderoncologie
The five-year survival of all children with acute lymphatic leukemia has continued to increase to…
Jul 22, 2023, 18:35 |
Stories
What from ASCO Annual Mtg ASCO23 should I know when I start my clinic on Monday? - Ishwaria Subbiah
A final tweak of the slides en route to Seattle for the 2023 Best of…
Jul 22, 2023, 18:24 |
Blog
ESMO has announced the recipients of the 2023 ESMO Society Awards - ESMO
ESMO has announced the recipients of the 2023 ESMO Society Awards based on recognition of…
Jul 22, 2023, 18:12 |
Stories
This is so heart warming - Bishal Gyawali
This is so heart warming. It made my day. Specially considering it came from Khalid…
Jul 22, 2023, 17:56 |
Drugs
High response rates in poor-risk population - Hagop Kantarjian
Our study of aza + ven + pevonedistat NEDD8-activating enzyme inhibitor in secondary AML &…
Jul 22, 2023, 17:39 |
Blog
Cervical cancer is a loud example of gender, health and social inequity - Union for International Cancer Control
“Cervical cancer is a loud example of gender, health and social inequity. Yet it is…
Jul 22, 2023, 05:47 |
Blog
Wonderful meeting w/ Penn Medicine med students participating in ASCO ’s Oncology Summer Internship program - Lynn M. Schuchter
Wonderful meeting w/ Penn Medicine med students participating in ASCO’s Oncology Summer Internship program! I…
Jul 22, 2023, 02:37 |
Career
Vincent Rajkumar appointed as the Chair-elect of the Board of the International Myeloma Foundation
According to the International Myeloma Foundation on Twitter, "World-Renowned Scientist, S. Vincent Rajkumar, MD, Appointed…
Jul 22, 2023, 02:20 |
Opinion
If I happened to get 10 new AML patients in one night - Amer Zeidan
Quoting Amer Zeidan on Twitter, "If I happened to get 10 new AML patients in…
Jul 21, 2023, 19:31 |
Career
We're thrilled to announce Eileen M. O'Reilly as the new Chair of PanCAN's Scientific and Medical Advisory Board - PanCAN
We're thrilled to announce Eileen M. O'Reilly, MD from Memorial Sloan Kettering Cancer Center as…
Jul 21, 2023, 19:18 |
Societies
ASCO has been awarded $11M of PCORI research funding to study CDK4/6 inhibitors dosing in older adults w metastatic breast cancer
In a post by ASCO on Twitter, it says, "We’re pleased to announce ASCO has…
Jul 21, 2023, 19:04 |
Career
ASTRO has selected 29 members to receive the ASTRO Fellow (FASTRO) designation - ASTRO
ASTRO has selected 29 members to receive the ASTRO Fellow (FASTRO) designation. Congratulations to the…
Jul 21, 2023, 18:53 |
Blog
Grateful to ASCO for prioritizing our well-being with SafeHaven™ - Toni Choueiri
Grateful to ASCO for prioritizing our well-being with SafeHaven™, a clinician well-being program! Thank you…
Jul 21, 2023, 18:38 |
Positive
A milestone was achieved last week at Gustave Roussy radiotherapy department - Eric Deutsch
A milestone was achieved last week at Gustave Roussy radiotherapy department with the arrival of the…
Jul 21, 2023, 18:21 |
Blog
Elsevier's revenue: £2.9 billion - Melanie Conrad
Elsevier's revenue: £2.9 billion. WTF? We scientists produce the content for manuscripts and review for…
Jul 21, 2023, 18:08 |
Blog
Honestly, sometimes that feels like we fail our patients - Kathrin Heinrich
As oncologist I am familiar with pain, loss and grief. But losing patients my own…
Jul 21, 2023, 17:47 |
Blog
Pediatric oncology: the right to be forgotten with a team effort by AIEOP and FIAGOP
In a post by AIEOP on Linkedin, it says, "HOT OFF THE PRESS - Pediatric…
Jul 20, 2023, 18:05 |
Blog
But it is also the best treatment for thallium poisoning - David Steensma
Hematologists think of Prussian Blue as a reagent for highlighting iron in the marrow, including…
Jul 20, 2023, 17:52 |
Career
Prof. dr. Marcel Kool has been appointed professor of Childhood brain tumors at UMC Utrecht - Prinses Máxima Centrum voor kinderoncologie
Prof. dr. Marcel Kool has been appointed professor of Childhood brain tumors at UMC Utrecht. With…
Jul 20, 2023, 17:26 |
Societies
Join SGO's online forum for allied health professionals specializing in gynecologic oncology - SGO
Join SGO's online forum for allied health professionals specializing in gynecologic oncology. Members discuss various…
Jul 20, 2023, 17:15 |
Blog
The scarcity of approvals in brain & head & neck - Jean-Charles Soria
FDA oncology approvals by disease site since 2000 illustrates ❶ the high number of approvals…
Jul 20, 2023, 17:03 |
Positive
It’s time for a paradigm shift in healthcare - Tommy Ibrahim
We’re used to a healthcare model that sees patients as passive recipients of medical interventions,…
Jul 20, 2023, 16:44 |
Blog
I was amazed how much I had to change - Kathrin Heinrich
While updating the presentation (~ 5 years old) for a student's lecture on colorectal cancer…
Jul 20, 2023, 16:25 |
Blog
The moment I've been waiting for is finally here - Daniela Urueta
Just hit the 'Submit' button on my Hematology Oncology Fellowship application! The moment I've been…
Jul 20, 2023, 16:11 |
Blog
SOHO meeting of hematologic malignancies is coming to MENA region - Amer Zeidan
Exxcited that after almost a year of planning, SOHO meeting of hematologic malignancies is coming…
Jul 20, 2023, 06:34 |
Opinion
We need our profession societies ASCO and ASH to stand up and represent us - Aaron Goodman
We need our profession societies ASCO and ASH to stand up and represent us and…
Jul 20, 2023, 06:17 |
Blog
Applications are open for our International Development and Education Award (IDEA) program - American Society of Clinical Oncology
Applications are open for our International Development and Education Award (IDEA) program, which provides support…
Jul 20, 2023, 05:57 |
Opinion
ESMO proposes principles to improve Sponsoring and Monitoring of Clinical Trials and promote patient welfare - Jose Luis Perez-Garcia
1/ Bureaucracy is overwhelming Clinical Research! ESMO proposes principles to improve Sponsoring and Monitoring of…
Jul 19, 2023, 18:54 |
Positive
Empowering Voices of Triumph: Listen to The Health After Cancer Podcast
Discover The Health After Cancer Podcast - a powerful website featuring podcasts with inspiring cancer…
Jul 19, 2023, 18:34 |
Insight
In breast oncology there is a pre-TDXd & a post-TDXd era, with the latter still at the dawn - Paolo Tarantino
In breast oncology there is a pre-TDXd & a post-TDXd era, with the latter still…
Jul 19, 2023, 18:24 |
Blog
ADCs have changed the way we treat breast cancer and there is much more to come - Guilherme Nader Marta
ADCs have changed the way we treat breast cancer and there is much more to…
Jul 19, 2023, 18:16 |
Career
Honored to receive a cancer research institute Irvington Postdoctoral Fellowship - Valentin Barthet
Honored to receive a Cancer Research Institute Irvington Postdoctoral Fellowship to investigate how oncogene-induced senescence…
Jul 19, 2023, 18:03 |
Drugs
Impact of TMB, PD-L1 , genomic features, and pneumonitis on CRT and durvalumab response in stage III NSCLC - João Alessi
Glad to share our paper recently published in Nature. In which, we report the impact…
Jul 19, 2023, 15:05 |
Blog
Richard is a talented scientist and humanitarian, generous, kind and selfless - Todd Harper
The remarkable story of Professor Richard Scolyer AO. A gifted cancer scientist and now a…
Jul 19, 2023, 14:45 |
Stories
I have worked with hundreds of people affected by cancer and their families for the past several years - Ani Haykuni
Have you ever thought what happens when you hate a disease in your body? I…
Jul 19, 2023, 14:27 |
Societies
FLASCO Cancer Disparities and Health Equity Summit happening on November 3-4, 2023 in Hollywood, FL - Florida Society of Clinical Oncology
Join us for the highly anticipated FLASCO Cancer Disparities and Health Equity Summit happening on…
Jul 18, 2023, 20:31 |
Career
Congrats to Amir Iravani on being been selected as the recipient of a $1M SNMMI Mars Shot Fund Grant - Fred Hutchinson Cancer Center
Congrats to Amir Iravani on being been selected as the recipient of a $1M SNMMI…
Jul 18, 2023, 20:19 |
Positive
Families facing childhood cancer need educational resources they can trust - Daniel Bastardo Blanco
Last week, my team grew, and I couldn’t be more excited! Eluz and Randa joined our team as…
Jul 18, 2023, 20:06 |
Blog
I argue that crossover should not be “allowed”- they should either be “mandated” or “prohibited” - Bishal Gyawali
Hot off the press in NatureRevClinOncol! Using examples from trials presented at ASCO23, in this…
Jul 18, 2023, 19:54 |
Stories
Time to do NGS on all cancers, and study every cancer molecularly/genetically - Sucharu Prakash
It is time! Time to do NGS on all cancers, and study every cancer molecularly/genetically.…
Jul 18, 2023, 19:39 |
Drugs
Venetoclax helps to eliminate the adverse prognostic impact of splicing factor mutations in pts with newly diagnosed AML
Quoting Hagop Kantarjian on Twitter, "MD Anderson Cancer Center's Leukemia researchers identify the use of venetoclax…
Jul 18, 2023, 19:20 |
Career
She returns to the institution as an instructor in NeuroOnc - Amar Gajjar
Quoting Amar Gajjar on Twitter, "Eight years ago, Dana Tlais completed a clinical elective at…
Jul 18, 2023, 19:06 |
Blog
Your annual reminder - Shematologist
Not sure who needs to hear this but not all microcytic anemia is iron deficiency.…
Jul 18, 2023, 18:50 |
Blog
Excellent summary of the progress being made for use of ctDNA in developing new cancer treatments - Jeff Allen
Excellent summary of our recent project results and the progress being made for use of…
Jul 18, 2023, 05:37 |
Blog
Positive topline results from the Phase 3 PAPILLON study in patients with non-small cell lung cancer - Kiran Patel
Today, The Janssen Pharmaceutical Companies of Johnson & Johnson announced positive topline results from the…
Jul 18, 2023, 05:31 |
Blog
IASLC grant opportunities for our July 2023 funding cycle!
NOW ACCEPTING APPLICATIONS for IASLC grant opportunities for our July 2023 funding cycle! The IASLC…
Jul 18, 2023, 05:23 |
Blog
The call for proposals for the hosting of the 2025 SIOP ASIA Congress - International Society of Paediatric Oncology
The call for proposals for the hosting of the 2025 SIOP ASIA Congress has been…
Jul 18, 2023, 05:14 |
Opinion
October issue of The Art Talk Magazine - the "Pink Edition" - will support breast cancer research - Carolina Conforti
Good afternoon and good morning wherever you are in the art work! The Art Talk…
Jul 17, 2023, 18:45 |
Opinion
I aspire to be like Suresh Ramalingam - Christine Lovly
I aspire to be like Suresh S. Ramalingam. The depth and breadth of his involvement…
Jul 17, 2023, 18:18 |
Stories
Oncology, I love you, you do great, hard work, but - Kevin Hageman
Oncology, I love you, you do great, hard work, but the primary team does not…
Jul 17, 2023, 18:07 |
Societies
ESMO Members are invited to vote for the candidates running for the ESMO Nomination Committee Chair and four Member positions - ESMO
ESMO Members are invited to vote for the candidates running for the ESMO Nomination Committee Chair…
Jul 17, 2023, 17:57 |
Blog
Body image disturbances in AYA cancer patients confronting infertility risk and fertility preservation decisions - Nina Jackson Levin
Proud to share this our newest article “Body image disturbances in AYA cancer patients confronting…
Jul 17, 2023, 17:30 |
Societies
Pink Sari Inc is run by a dynamo of female community leaders from diverse language groups from the Indian sub-continent - Tracey O'Brien
One of the best parts about working at the Cancer Institute NSW is the strong partnerships with…
Jul 17, 2023, 09:59 |
Opinion
Zenocutuzumab has rec’d Breakthrough Designation (BTD) from US FDA for NRG1+ NSCLC - Debyani Chakravarty
My OncoKB people: Zenocutuzumab has rec’d Breakthrough Designation (BTD) from US FDA for NRG1+ NSCLC.…
Jul 17, 2023, 09:51 |
Insight
Big shout out to Conquer Cancer, the ASCO Foundation for supporting young researchers from all over the world - Akhil Santhosh
2nd ASCO merit award in 3 months.. Official announcement from ASCO breakthrough team Big shout…
Jul 17, 2023, 09:41 |
Opinion
Bereavement is likely not in the curricula for oncology fellows this July, maybe not at all over 3 years. It should be - Ramy Sedhom
Recently, I lost a pt I really liked. Surprisingly, during a brief 15 min bereavement…
Jul 17, 2023, 09:31 |
Insight
Heteroleptic bipyridine PdII-Bian complexes were cytotoxic in a low micromolar concentration range and demonstrated some selectivity toward cancer cells compared to noncancerous MRC-5 lung fibroblasts - Jemma Arakelyan
Jul 17, 2023, 07:12 |
Blog
KN495 updated clinical manuscript entitled “Biomarker-directed, pembrolizumab-based combination therapy in non-small cell lung cancer: phase 2 KEYNOTE-495/KeyImPaCT trial interim results” has been epublished by Nature Medicine on July 10
Jul 17, 2023, 07:00 |
Blog
Get involved with Common Sense Oncology - Aaron Goodman
Get involved with Common Sense Oncology We have research initiatives/action plans in our 3 core…
Jul 17, 2023, 06:50 |
Societies
Paediatric Cancer Nurses - Survey
In a post by AIEOP on Linkedin, it says, "ATTENTION: PAEDIATRIC CANCER NURSES -…
Jul 17, 2023, 06:35 |
Blog
The future is definitely bright - Matteo Lambertini
What a fantastic class at Eur. Oncology course on medical oncology for medical students: the…
Jul 16, 2023, 23:17 |
Opinion
This Common Sense Oncology (CSO) manifesto is a must read for the oncology community - Nina Niu Sanford
Quoting Dr. Nina Niu Sanford on Twitter, "This Common Sense Oncology (CSO) manifesto is a…
Jul 16, 2023, 23:07 |
Societies
The Common Sense Oncology movement aims to redirect oncology back to what really matters to patients - Aaron Goodman
Introducing Common Sense Oncology! The Common Sense Oncology movement aims to redirect oncology back to…
Jul 16, 2023, 14:35 |
Drugs
Lenalidomide (Revlimid) used to cost $324/pill back in 2009, Now is $1,000/pill - Michael Lam
Lenalidomide (Revlimid) used to cost $324/pill back in 2009. Now is $1,000/pill. Gradually increase the…
Jul 16, 2023, 14:26 |
Blog
Latin American Cancer Research Network (LACRN) has achieved a major milestone - Javier Retamales
🌍 Global Research News! 📢 The Latin American Cancer Research Network (LACRN) has achieved a…
Jul 16, 2023, 07:20 |
Blog
To bring liquid biopsy testing for Burkitts lymphoma to children in East Africa - Anna Schuh
With 35 wonderful colleagues from Oxford Oncology, NHLDS, Lacor, Muhimbili University, Muhimbili National Hospital KCMC,…
Jul 16, 2023, 07:10 |
Drugs
We are proud to join with AARP and 35 other orgs to push for competition to lower drug prices - David Mitchell
We are proud to join with AARP and 35 other orgs to push for competition…
Jul 16, 2023, 07:02 |
Stories
Let's hope that all liposarcoma patients and their doctors will hear all about the clinical trial Brightline - Kathi Apostolidis
This is encouraging news for patients with a very rare cancer, liposarcoma, who had not…
Jul 16, 2023, 06:48 |
Stories
Therapy Resistance and Metabolic reprogramming in ER+ breast cancer: what a combo - Andrea Morandi
📣 It's OUT! Therapy Resistance and Metabolic reprogramming in ER+ breast cancer: what a combo!…
Jul 16, 2023, 06:47 |
Blog
Google Bard is UNBELIEVABLE when it comes to image processing - Dr. Iyad Sultan
Google Bard is UNBELIEVABLE when it comes to image processing. Here are examples: First, I…
Jul 16, 2023, 06:35 |
Career
Meet the newly elected IASLC board members including President-Elect Caicun Zhou, MD, PhD - IASLC
Meet the newly elected IASLC board members who will begin their terms at WCLC23, including…
Jul 16, 2023, 06:28 |
Blog
If you know someone diagnosed with cancer before turning 39 and living in Europe, please share the survey with them - Youth Cancer Europe
🫵Your voice matters! Youth Cancer Europe is leading Work Package 5 on Equality, Diversity, and…
Jul 15, 2023, 18:38 |
Career
Moffitt has named Brian D. Gonzalez, Ph.D., as the inaugural associate center director of Research Diversity and Workforce Development - Moffitt Cancer Center
Moffitt has named Brian D. Gonzalez, Ph.D., as the inaugural associate center director of Research…
Jul 15, 2023, 18:26 |
Blog
Status of peer review in radiation therapy in Africa - Omar AbdiHamid
publication Alert 🚨🔔 Happy to share our work with the able Fidel Rubagumya ,M.D, MMed, MPH ,M.D,…
Jul 15, 2023, 18:12 |
Blog
The healthcare workforce is facing a serious crisis - European Cancer Organisation
The healthcare workforce is facing a serious crisis. We can help stop it! 📣 ECO…
Jul 15, 2023, 17:54 |
Career
Congratulations to the newly elected members of ASTRO’s Board of Directors - ASTRO
Congratulations to the newly elected members of ASTRO’s Board of Directors. The new officers’ terms…
Jul 15, 2023, 17:43 |
Drugs
Awesome talk by Dr. Rana McKay on the future perspectives of new drugs and compounds in RCC - Fabio Schutz
Awesome talk by Dr. Rana McKay on the future perspectives of new drugs and compounds…
Jul 15, 2023, 17:30 |
Career
Congratulations to Dr. Chanita Hughes-Halbert who was awarded a two-year grant from Merck - Caryn Lerman
Congratulations to Dr. Chanita Hughes-Halbert, Associate Director for Cancer Equity at USC Norris and Professor of…
158
159
160
161
162
All:
16280
Posts:
15901 - 16000
A Manifesto to Improve Cancer Care in Conflict-Affected Areas: The Lancet
Why does Lionel Messi donate so much to charity?
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
Facebook
RSS Feed
Twitter
Linkedin
Youtube